Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Alan Fu"'
Autor:
Fengqin Shi, Ya Li, Rui Han, Alan Fu, Ronghua Wang, Olivia Nusbaum, Qin Qin, Xinyi Chen, Li Hou, Yong Zhu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect d
Externí odkaz:
https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff
Autor:
Suying Li, Haifeng Guo, Yi Peng, Tingting Gong, Alan Fu, Debajyoti Bhowmik, Rohini K. Hernandez, Katherine B. Carlson, Kimberly A. Lowe, Jitesh Rana, Shuling Li
Publikováno v:
Journal of Bone Oncology, Vol 26, Iss , Pp 100328- (2021)
Background: Previous studies have quantified direct inpatient costs of skeletal-related events (SREs); however, costs associated with subsequent post-SRE care have not been examined. Methods: We identified two study cohorts using 2011–2015 Medicare
Externí odkaz:
https://doaj.org/article/2a2cc7621a0c45d4b85836b6d409742a
Autor:
Carma L Bylund, Susan Eggly, Thomas W LeBlanc, Sandra Kurtin, Marianne Gandee, Rohan Medhekar, Alan Fu, Monica Khurana, Kara Delaney, Alecia Divita, Michelle McNamara, Walter F Baile
Publikováno v:
Translational Behavioral Medicine. 13:255-267
Shared decision-making (SDM) is a key component of patient-centered healthcare. SDM is particularly pertinent in the relapsed and/or refractory multiple myeloma (RRMM) setting, in which numerous treatment options can present challenges for identifyin
Autor:
Shuling Li, Brandon T. Suehs, Alan Fu, Laura Sangaré, Chris Kim, Victor M. Gastanaga, Jiannong Liu, Heng Yan, Yihua Xu, Joseph Mikhael
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Background: Metabolic dysregulation has been identified as an “emerging hallmark” of cancer. The heterotrimeric AMP-activated protein kinase (AMPK) complex is a central regulator of the metabolic system and an important component of the mTOR path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a9bab56e4bc7d4d6760da32fb69ad99
https://doi.org/10.1158/1055-9965.c.6515305
https://doi.org/10.1158/1055-9965.c.6515305
Autor:
Yong Zhu, Haifan Lin, Guilin Wang, Andrew T. DeWan, Elizabeth B. Claus, Robert Dubrow, Alan Fu, Michael C. Lerro, Qin Qin, Daniel I. Jacobs
Supplementary Table 1. Primers used for qPCR reactions and piRNA mimics used for in vitro functional analyses.Supplementary Table 2. Characteristics of GliomaScan subjects included in piRNA SNP imputation and association analysis. Supplementary Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94bc7769a4db2becc4ceb6cf84d85598
https://doi.org/10.1158/1055-9965.22436446.v1
https://doi.org/10.1158/1055-9965.22436446.v1
Background: miRNAs have been implicated in numerous tumorigenic pathways, and previous studies have associated miR-202 dysregulation with various cancer types, including follicular lymphoma.Methods: The miR-202 targetome was identified by ribonucleop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d07c8bc2b255089dee7f94b490b80f
https://doi.org/10.1158/1055-9965.c.6515446.v1
https://doi.org/10.1158/1055-9965.c.6515446.v1
Autor:
Yong Zhu, Haifan Lin, Guilin Wang, Andrew T. DeWan, Elizabeth B. Claus, Robert Dubrow, Alan Fu, Michael C. Lerro, Qin Qin, Daniel I. Jacobs
Background: PIWI-interacting RNAs (piRNAs), the largest class of noncoding RNAs in mammals, cooperate with PIWI proteins to safeguard the genome from insertional mutations during germline development. Although a growing number of studies have linked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08445ba3fc57a42d8741a49fe497f631
https://doi.org/10.1158/1055-9965.c.6515404.v1
https://doi.org/10.1158/1055-9965.c.6515404.v1
XLSX file - 40K, Genetic polymorphisms of AMPK-associated genes and risk of NHL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198ad76e213bea1157d6405c94ca772c
https://doi.org/10.1158/1055-9965.22436269
https://doi.org/10.1158/1055-9965.22436269
Autor:
Monika A. Izano, Nguyet Tran, Alan Fu, Liz Toland, Danny Idryo, Ryan Hilbelink, Huakang Tu, Hil Hsu, Chris Sommers, Matthew Rioth, Thomas Brown
Publikováno v:
Clinical Lung Cancer. 23:191-194
To accelerate drug approvals while maintaining scientific rigor in the evaluation of a therapeutic's efficacy and safety, the United States Food and Drug Administration now considers real-world data (RWD) to support New Drug Applications and expanded